{"transactions":[{"id":748043,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-05T21:20:18.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":7433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in equal quarterly installments over the 12 months following June 3, 2026, provided that the grant will in any case be fully vested on the date of Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":7433,"derivative":{"exercise_price":10.5,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":7433},"source":{"system":"sec-edgar","filing":"0001721020-26-000004","document":"form4-06052026_090614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1721020/000172102026000004/form4-06052026_090614.xml","form_type":"4"}},{"id":748042,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:20:18.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":7142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs fully vest on the earlier of (A) June 3, 2027 and (B) the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":12392,"source":{"system":"sec-edgar","filing":"0001721020-26-000004","document":"form4-06052026_090614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721020/000172102026000004/form4-06052026_090614.xml","form_type":"4"}},{"id":748039,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:15:31.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":2625,"price":10.72,"value":28140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.60 to $10.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9767,"source":{"system":"sec-edgar","filing":"0001721020-26-000002","document":"form4-06052026_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721020/000172102026000002/form4-06052026_040607.xml","form_type":"4"}},{"id":1010189,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-11-03T22:25:08.000Z","date":"2025-10-30","kind":"grant","planned":false,"acquired":true,"shares":3777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders."}],"balance_after":3777,"derivative":{"exercise_price":60.96,"expiration_date":"2035-10-30","underlying":"Common Stock","underlying_shares":3777},"source":{"system":"sec-edgar","filing":"0000914190-25-000020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419025000020/form4.xml","form_type":"4"}},{"id":1010188,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T22:25:08.000Z","date":"2025-10-30","kind":"grant","planned":false,"acquired":true,"shares":1640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15411,"source":{"system":"sec-edgar","filing":"0000914190-25-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419025000020/form4.xml","form_type":"4"}},{"id":1119710,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T20:15:12.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":10500,"derivative":{"exercise_price":14.82,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001415889-25-015975","document":"form4-06062025_040608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1721020/000141588925015975/form4-06062025_040608.xml","form_type":"4"}},{"id":1119709,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:15:12.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs fully vest on the earlier of (A) June 4, 2026 and (B) the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001415889-25-015975","document":"form4-06062025_040608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721020/000141588925015975/form4-06062025_040608.xml","form_type":"4"}},{"id":1380906,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-10-28T20:41:00.000Z","date":"2024-10-24","kind":"grant","planned":false,"acquired":true,"shares":3511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders."}],"balance_after":3511,"derivative":{"exercise_price":68.37,"expiration_date":"2034-10-24","underlying":"Common Stock","underlying_shares":3511},"source":{"system":"sec-edgar","filing":"0001062993-24-018029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324018029/form4.xml","form_type":"4"}},{"id":1380905,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-28T20:41:00.000Z","date":"2024-10-24","kind":"grant","planned":false,"acquired":true,"shares":1462,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13771,"source":{"system":"sec-edgar","filing":"0001062993-24-018029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324018029/form4.xml","form_type":"4"}},{"id":1495206,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:15:22.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":10000,"derivative":{"exercise_price":46.31,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-015156","document":"form4-06032024_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721020/000141588924015156/form4-06032024_040618.xml","form_type":"4"}},{"id":1709883,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-12-15T18:24:45.000Z","date":"2023-12-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2044,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit granted after March 12, 2023 that was unvested as of immediately prior to the Effective Time (each, a \"Post-Signing Company RSU\") was cancelled and converted into the right to receive a Parent cash-based award subject to service-based vesting requirements with respect to an amount in cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Post-Signing Company RSU."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of shares of common stock, par value $0.001 per share (\"Common Stock\"), of Seagen Inc. (\"Issuer\"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Parent\") and Aris Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit granted after March 12, 2023 that was unvested as of immediately prior to the Effective Time (each, a \"Post-Signing Company RSU\") was cancelled and converted into the right to receive a Parent cash-based award subject to service-based vesting requirements with respect to an amount in cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Post-Signing Company RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit granted after March 12, 2023 that was unvested as of immediately prior to the Effective Time (each, a \"Post-Signing Company RSU\") was cancelled and converted into the right to receive a Parent cash-based award subject to service-based vesting requirements with respect to an amount in cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Post-Signing Company RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock unit granted after March 12, 2023 that was unvested as of immediately prior to the Effective Time (each, a \"Post-Signing Company RSU\") was cancelled and converted into the right to receive a Parent cash-based award subject to service-based vesting requirements with respect to an amount in cash equal to the product of (i) the Merger Consideration, multiplied by (ii) the number of shares of Common Stock then subject to such Post-Signing Company RSU."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":2044},"source":{"system":"sec-edgar","filing":"0000950170-23-070868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000095017023070868/ownership.xml","form_type":"4"}},{"id":1709882,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-15T18:24:45.000Z","date":"2023-12-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3676,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of shares of common stock, par value $0.001 per share (\"Common Stock\"), of Seagen Inc. (\"Issuer\"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Parent\") and Aris Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."}],"balance_after":0,"derivative":{"exercise_price":135.63,"expiration_date":"2032-05-13","underlying":"Common stock","underlying_shares":3676},"source":{"system":"sec-edgar","filing":"0000950170-23-070868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000095017023070868/ownership.xml","form_type":"4"}},{"id":1709881,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-15T18:24:45.000Z","date":"2023-12-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3462,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of shares of common stock, par value $0.001 per share (\"Common Stock\"), of Seagen Inc. (\"Issuer\"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Parent\") and Aris Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."}],"balance_after":0,"derivative":{"exercise_price":147.5,"expiration_date":"2031-05-14","underlying":"Common stock","underlying_shares":3462},"source":{"system":"sec-edgar","filing":"0000950170-23-070868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000095017023070868/ownership.xml","form_type":"4"}},{"id":1709880,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-15T18:24:45.000Z","date":"2023-12-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3171,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of shares of common stock, par value $0.001 per share (\"Common Stock\"), of Seagen Inc. (\"Issuer\"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Parent\") and Aris Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."}],"balance_after":0,"derivative":{"exercise_price":160.33,"expiration_date":"2030-05-15","underlying":"Common stock","underlying_shares":3171},"source":{"system":"sec-edgar","filing":"0000950170-23-070868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000095017023070868/ownership.xml","form_type":"4"}},{"id":1709879,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-15T18:24:45.000Z","date":"2023-12-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7038,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of shares of common stock, par value $0.001 per share (\"Common Stock\"), of Seagen Inc. (\"Issuer\"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Parent\") and Aris Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."}],"balance_after":0,"derivative":{"exercise_price":64.38,"expiration_date":"2029-05-20","underlying":"Common stock","underlying_shares":7038},"source":{"system":"sec-edgar","filing":"0000950170-23-070868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000095017023070868/ownership.xml","form_type":"4"}},{"id":1709878,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-12-15T18:24:45.000Z","date":"2023-12-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of shares of common stock, par value $0.001 per share (\"Common Stock\"), of Seagen Inc. (\"Issuer\"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Parent\") and Aris Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each outstanding option, whether or not then vested, was cancelled in exchange for the right to receive an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the per-share exercise price of such option, multiplied by (ii) the number of shares of Common Stock then subject to such option."}],"balance_after":0,"derivative":{"exercise_price":57.68,"expiration_date":"2028-03-15","underlying":"Common stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0000950170-23-070868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000095017023070868/ownership.xml","form_type":"4"}},{"id":1709877,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-15T18:24:45.000Z","date":"2023-12-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12953,"price":229,"value":2966237.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of shares of common stock, par value $0.001 per share (\"Common Stock\"), of Seagen Inc. (\"Issuer\"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Parent\") and Aris Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the disposition of shares of common stock, par value $0.001 per share (\"Common Stock\"), of Seagen Inc. (\"Issuer\"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Parent\") and Aris Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of shares of common stock, par value $0.001 per share (\"Common Stock\"), of Seagen Inc. (\"Issuer\"), or of equity awards in respect of such Common Stock, as applicable, in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of March 12, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Parent\") and Aris Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Parent, pursuant to which, at 12:01 a.m. EST on December 14, 2023, the effective time of the Merger (the \"Effective Time\"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each issued and outstanding share of Common Stock (other than certain excluded shares described in the Merger Agreement) was cancelled and converted automatically into the right to receive cash in an amount equal to $229.00 per share of Common Stock (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-23-070868","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000095017023070868/ownership.xml","form_type":"4"}},{"id":1754073,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-10-30T20:55:45.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":3937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders."}],"balance_after":3937,"derivative":{"exercise_price":61.51,"expiration_date":"2033-10-26","underlying":"Common Stock","underlying_shares":3937},"source":{"system":"sec-edgar","filing":"0001062993-23-019858","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323019858/form4.xml","form_type":"4"}},{"id":1754072,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-30T20:55:45.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12309,"source":{"system":"sec-edgar","filing":"0001062993-23-019858","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323019858/form4.xml","form_type":"4"}},{"id":1862439,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T20:47:00.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":10000,"derivative":{"exercise_price":48.79,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-23-035463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721020/000120919123035463/doc4.xml","form_type":"4"}},{"id":1870676,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T18:20:58.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":2044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities are restricted stock units and will be settled in common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units shall vest in full on May 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":14997,"source":{"system":"sec-edgar","filing":"0001203311-23-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331123000060/edgardoc.xml","form_type":"4"}},{"id":1906216,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-03T20:45:44.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12th) of the shares subject to the option shall vest in equal quarterly installments commencing on August 1, 2023, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":20000,"derivative":{"exercise_price":46.07,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-026998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721020/000120919123026998/doc4.xml","form_type":"4"}},{"id":2130075,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-31T21:18:12.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders."}],"balance_after":865,"derivative":{"exercise_price":295.77,"expiration_date":"2032-10-27","underlying":"Common Stock","underlying_shares":865},"source":{"system":"sec-edgar","filing":"0001415889-22-010912","document":"form4-10312022_021056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922010912/form4-10312022_021056.xml","form_type":"4"}},{"id":2130074,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-31T21:18:12.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":338,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2671,"source":{"system":"sec-edgar","filing":"0001415889-22-010912","document":"form4-10312022_021056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922010912/form4-10312022_021056.xml","form_type":"4"}},{"id":2268746,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-05-17T19:35:11.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":3676,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3676,"derivative":{"exercise_price":135.63,"exercise_date":"2023-05-13","expiration_date":"2032-05-13","underlying":"Common Stock","underlying_shares":3676},"source":{"system":"sec-edgar","filing":"0000899243-22-018467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322018467/doc4.xml","form_type":"4"}},{"id":2268745,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-17T19:35:11.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":1503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units will be settled in common stock upon vesting."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units shall vest in full on May 13, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":12953,"source":{"system":"sec-edgar","filing":"0000899243-22-018467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322018467/doc4.xml","form_type":"4"}},{"id":2531226,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-01T20:36:38.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the earlier of the one year anniversary of the grant date (10/28/2021) or the date of Bio-Techne's 2022 annual meeting of shareholders."}],"balance_after":633,"derivative":{"exercise_price":515.24,"expiration_date":"2031-10-28","underlying":"Common Stock","underlying_shares":633},"source":{"system":"sec-edgar","filing":"0000914190-21-000395","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000395/edgar.xml","form_type":"4"}},{"id":2531225,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-01T20:36:38.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":194,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2333,"source":{"system":"sec-edgar","filing":"0000914190-21-000395","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000395/edgar.xml","form_type":"4"}},{"id":2708747,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-18T19:26:58.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":3462,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3462,"derivative":{"exercise_price":147.5,"exercise_date":"2022-05-14","expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":3462},"source":{"system":"sec-edgar","filing":"0001203311-21-000031","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331121000031/edgardoc.xml","form_type":"4"}},{"id":2708746,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-18T19:26:58.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":1402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units will be settled in common stock upon vesting."},{"field":"date","element":"transactionDate","label":"F2","text":"These restricted stock units shall vest in full on May 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":11450,"source":{"system":"sec-edgar","filing":"0001203311-21-000031","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331121000031/edgardoc.xml","form_type":"4"}},{"id":2973811,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T17:27:48.000Z","date":"2020-11-09","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable"}],"balance_after":0,"derivative":{"exercise_price":125.05,"expiration_date":"2027-10-26","underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001562180-20-006793","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006793/primarydocument.xml","form_type":"4"}},{"id":2973810,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T17:27:48.000Z","date":"2020-11-09","kind":"exercise","acquired":false,"shares":1898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable"}],"balance_after":0,"derivative":{"exercise_price":179.84,"expiration_date":"2028-10-25","underlying":"Common Stock","underlying_shares":1898},"source":{"system":"sec-edgar","filing":"0001562180-20-006793","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006793/primarydocument.xml","form_type":"4"}},{"id":2973809,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T17:27:48.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":3665,"price":306.95,"value":1124971.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $306.84 to $307.26, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2139,"source":{"system":"sec-edgar","filing":"0001562180-20-006793","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006793/primarydocument.xml","form_type":"4"}},{"id":2973808,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T17:27:48.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":1358,"price":305.74,"value":415194.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $305.72 to $305.79, inclusive.  The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5804,"source":{"system":"sec-edgar","filing":"0001562180-20-006793","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006793/primarydocument.xml","form_type":"4"}},{"id":2973807,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T17:27:48.000Z","date":"2020-11-09","kind":"exercise","acquired":true,"shares":3125,"price":125.05,"value":390781.25,"ownership":{"direct":true},"balance_after":7162,"source":{"system":"sec-edgar","filing":"0001562180-20-006793","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006793/primarydocument.xml","form_type":"4"}},{"id":2973806,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T17:27:48.000Z","date":"2020-11-09","kind":"exercise","acquired":true,"shares":1898,"price":179.84,"value":341336.32,"ownership":{"direct":true},"balance_after":4037,"source":{"system":"sec-edgar","filing":"0001562180-20-006793","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006793/primarydocument.xml","form_type":"4"}},{"id":2996899,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-02T20:11:54.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne 2021 annual meeting of shareholders."}],"balance_after":1507,"derivative":{"exercise_price":255.69,"expiration_date":"2030-10-29","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001562180-20-006487","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006487/primarydocument.xml","form_type":"4"}},{"id":2996898,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-02T20:11:54.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2139,"source":{"system":"sec-edgar","filing":"0001562180-20-006487","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006487/primarydocument.xml","form_type":"4"}},{"id":3143486,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-19T19:11:03.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":3171,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3171,"derivative":{"exercise_price":160.33,"exercise_date":"2021-05-15","expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":3171},"source":{"system":"sec-edgar","filing":"0001203311-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331120000050/edgardoc.xml","form_type":"4"}},{"id":3143485,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-19T19:11:03.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":1335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units will be settled in common stock upon vesting."},{"field":"date","element":"transactionDate","label":"F2","text":"These restricted stock units shall vest in full on May 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":10048,"source":{"system":"sec-edgar","filing":"0001203311-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331120000050/edgardoc.xml","form_type":"4"}},{"id":3387376,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-10-28T20:59:34.000Z","date":"2019-10-24","kind":"grant","acquired":true,"shares":2011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne's 2020 annual meeting of shareholders."}],"balance_after":2011,"derivative":{"exercise_price":201.64,"expiration_date":"2029-10-24","underlying":"Common Stock","underlying_shares":2011},"source":{"system":"sec-edgar","filing":"0001624404-19-000011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000162440419000011/edgar.xml","form_type":"4"}},{"id":3387375,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-28T20:59:34.000Z","date":"2019-10-24","kind":"grant","acquired":true,"shares":495,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1748,"source":{"system":"sec-edgar","filing":"0001624404-19-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000162440419000011/edgar.xml","form_type":"4"}},{"id":3515696,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-05-22T21:41:45.000Z","date":"2019-05-20","kind":"grant","acquired":true,"shares":7038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options shall vest in full on May 20, 2020."}],"balance_after":7038,"derivative":{"exercise_price":64.38,"expiration_date":"2029-05-20","underlying":"Common Stock","underlying_shares":7038},"source":{"system":"sec-edgar","filing":"0000899243-19-014438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924319014438/doc4.xml","form_type":"4"}},{"id":3515695,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T21:41:45.000Z","date":"2019-05-20","kind":"grant","acquired":true,"shares":2963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These restricted stock units will be settled in common stock upon vesting."},{"field":"date","element":"transactionDate","label":"F2","text":"These restricted stock units shall vest in full on May 20, 2020."}],"balance_after":8713,"source":{"system":"sec-edgar","filing":"0000899243-19-014438","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924319014438/doc4.xml","form_type":"4"}},{"id":3781904,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2018-10-29T21:07:03.000Z","date":"2018-10-25","kind":"grant","acquired":true,"shares":1898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests on the earlier of the one year anniversary of the grant date (10/25/2019) or the date of Bio-Techne 2019 Annual Meeting of Shareholders."}],"balance_after":1898,"derivative":{"exercise_price":179.84,"expiration_date":"2028-10-25","underlying":"Common Stock","underlying_shares":1898},"source":{"system":"sec-edgar","filing":"0001562180-18-004308","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018004308/primarydocument.xml","form_type":"4"}},{"id":3781903,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-29T21:07:03.000Z","date":"2018-10-25","kind":"grant","acquired":true,"shares":514,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1253,"source":{"system":"sec-edgar","filing":"0001562180-18-004308","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018004308/primarydocument.xml","form_type":"4"}},{"id":3994989,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-15T21:34:28.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares shall vest at a rate of 25% on 03/15/19 and monthly thereafter until all the shares are fully vested on 03/18/22."}],"balance_after":14250,"derivative":{"exercise_price":57.68,"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001203311-18-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000018/edgardoc.xml","form_type":"4"}},{"id":3994988,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-15T21:34:28.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units and will be settled in common stock upon vesting."},{"field":"date","element":"transactionDate","label":"F2","text":"Restricted Stock units shall vest in full on March 15, 2021."}],"balance_after":5750,"source":{"system":"sec-edgar","filing":"0001203311-18-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331118000018/edgardoc.xml","form_type":"4"}},{"id":4178934,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2017-10-30T21:14:12.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/26/2017) or the date of Bio-Techne 2018 annual meeting of shareholders."}],"balance_after":3125,"derivative":{"exercise_price":125.05,"expiration_date":"2027-10-26","underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001562180-17-003386","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017003386/primarydocument.xml","form_type":"4"}},{"id":4178933,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":40943,"kind":"person","name":"Seth Alpna","position":1,"cik":"0001721020","reported_name":"Seth Alpna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-30T21:14:12.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":739,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":739,"source":{"system":"sec-edgar","filing":"0001562180-17-003386","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017003386/primarydocument.xml","form_type":"4"}}]}